Shenyang Xingqi Pharmaceutical Co Ltd (300573.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100002DV1

Price
33.96 CNY
Market cap
12.05 bn CNY
P/E (2025)
17.44
P/S (2025)
4.87
Dividend yield
3.83 %
Net margin
28.14 %
Return on equity (ROE)
35.18 %
Return on assets (ROA)
27.41 %

Shenyang Xingqi Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue1.94 bn CNY2.47 bn CNY
Gross profit1.52 bn CNY2.01 bn CNY
Operating income424.75 m CNY843.77 m CNY
EBIT408.42 m CNY804.71 m CNY
Net income338.06 m CNY695.86 m CNY
Diluted EPS – continuing operations1.93 CNY1.95 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shenyang Xingqi Pharmaceutical Co Ltd

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People's Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People's Republic of China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.